Watch this video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.
CCO faculty Paul Kwo, MD, answers FAQs in hepatitis B management including treatment candidacy and duration
Paul Kwo, MD: Expert commentary on closing HBV diagnosis and treatment gaps to reduce complications and effective approaches to patient monitoring
Kenneth Cusi, MD, FACP, FACE, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.